acetaminophen has been researched along with atenolol in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.44) | 18.7374 |
| 1990's | 2 (4.88) | 18.2507 |
| 2000's | 12 (29.27) | 29.6817 |
| 2010's | 20 (48.78) | 24.3611 |
| 2020's | 6 (14.63) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baljet, AV; Breimer, DD; Danhof, M; de Boer, AG; van Bree, JB; van Geyt, A | 1 |
| Breimer, DD; Danhof, M; de Boer, AG; de Lange, EC | 1 |
| Bouw, MR; Breimer, DD; Danhof, M; de Boer, AG; de Lange, EC; Mandema, JW | 1 |
| Ajala, AM; Goodwin, JA; Goodwin, SR; Josephson, GD | 1 |
| Anthony, NG; Kennedy, AR; McInnes, FJ; Wheate, NJ | 1 |
| Alonso, E; Aparicio, I; Bron, JE; Hampel, M; Leaver, MJ; Santos, JL; Taggart, JB | 1 |
| Gong, Z; Zhang, X | 1 |
| Jeong, CB; Kim, BM; Lee, JS; Lee, YM; Leung, KM; Park, HG; Rhee, JS | 1 |
| Hegazy, MA | 1 |
| Azaïs, A; Brosillon, S; Mendret, J; Petit, E | 1 |
| Abdelzaher, WY; Kamel, MY; Rofaeil, RR | 1 |
| Babbucci, M; Bargelloni, L; Blasco, J; Ferraresso, S; Hampel, M; Milan, M | 1 |
| Azaïs, A; Brosillon, S; Cazals, G; Mendret, J; Petit, E | 1 |
| Clasen, C; Re, IL; Smeets, A; Van den Mooter, G | 1 |
| Breadmore, MC; Gooley, AA; Guijt, RM; Mikhail, IE; Tehranirokh, M | 1 |
| Chinnaiyan, P; Jeyadharmarajan, J; Ramasamy, B | 1 |
| Correia, AT; de Oliveira, TMN; Guimarães, LL; Pisetta, AM; Roveri, V | 1 |
| Correia, AT; Guimarães, LL; Roveri, V; Toma, W | 1 |
| Corvini, PF; Demaria, F; Kolvenbach, BA; Suleiman, M; Zimmardi, C | 1 |
1 review(s) available for acetaminophen and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
40 other study(ies) available for acetaminophen and atenolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system.
Topics: Acetaminophen; Animals; Antipyrine; Atenolol; Brain; Central Nervous System; Computers; Diffusion; Drug Carriers; Injections, Intravenous; Injections, Intraventricular; Male; Models, Biological; Pharmacokinetics; Rats; Rats, Inbred Strains | 1989 |
Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain.
Topics: Acetaminophen; Animals; Atenolol; Blood-Brain Barrier; Brain; Chemical Phenomena; Chemistry, Physical; Hypotonic Solutions; Injections, Intravenous; Injections, Intraventricular; Isotonic Solutions; Male; Microdialysis; Pharmacokinetics; Rats; Rats, Wistar; Temperature | 1994 |
Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Analgesics, Non-Narcotic; Animals; Atenolol; Blood-Brain Barrier; Brain; Computer Simulation; Diffusion; Male; Microdialysis; Models, Biological; Pharmacokinetics; Rats; Rats, Wistar; Regression Analysis; Software | 1995 |
Undiagnosed Graves' Disease contributing to sleep disordered breathing in a child undergoing adenotonsillectomy.
Topics: Acetaminophen; Adenoidectomy; Adenoids; Analgesics, Non-Narcotic; Analgesics, Opioid; Antihypertensive Agents; Antithyroid Agents; Atenolol; Child; Fentanyl; Follow-Up Studies; Graves Disease; Humans; Hydrocodone; Hypertension; Male; Palatine Tonsil; Propylthiouracil; Sleep Apnea Syndromes; Tachycardia; Thyroid Gland; Tonsillectomy | 2008 |
Solid state stabilisation of the orally delivered drugs atenolol, glibenclamide, memantine and paracetamol through their complexation with cucurbit[7]uril.
Topics: Acetaminophen; Administration, Oral; Atenolol; Drug Stability; Glyburide; Macrocyclic Compounds; Memantine; Models, Molecular; Molecular Structure | 2010 |
Potential physiological effects of pharmaceutical compounds in Atlantic salmon (Salmo salar) implied by transcriptomic analysis.
Topics: Acetaminophen; Animals; Atenolol; Carbamazepine; Environmental Monitoring; Fish Proteins; Gene Expression; Gene Expression Profiling; Male; RNA, Messenger; Salmo salar; Water Pollutants, Chemical | 2010 |
Fluorescent transgenic zebrafish Tg(nkx2.2a:mEGFP) provides a highly sensitive monitoring tool for neurotoxins.
Topics: Acetaminophen; Animals; Animals, Genetically Modified; Atenolol; Atrazine; Axons; Central Nervous System; Embryo, Nonmammalian; Ethanol; Green Fluorescent Proteins; Hexachlorocyclohexane; Mefenamic Acid; Motor Neurons; Neurotoxins; Sensitivity and Specificity; Toxicity Tests; Zebrafish | 2013 |
Effect of pharmaceuticals exposure on acetylcholinesterase (AchE) activity and on the expression of AchE gene in the monogonont rotifer, Brachionus koreanus.
Topics: Acetaminophen; Acetylcholinesterase; Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Atenolol; Base Sequence; Biocatalysis; Carbamazepine; Chlorpyrifos; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Helminth Proteins; Molecular Sequence Data; Oxytetracycline; Reverse Transcriptase Polymerase Chain Reaction; Rotifera; Sulfamethoxazole; Time Factors; Trimethoprim; Water Pollutants, Chemical; Xenobiotics | 2013 |
A novel pure component contribution algorithm (PCCA) for extracting components' contribution from severely overlapped signals; an application to UV-spectrophotometric data.
Topics: Acetaminophen; Algorithms; Amiloride; Atenolol; Capsules; Hydrochlorothiazide; Ibuprofen; Spectrophotometry, Ultraviolet; Tablets | 2015 |
Influence of volumetric reduction factor during ozonation of nanofiltration concentrates for wastewater reuse.
Topics: Acetaminophen; Atenolol; Carbamazepine; Diatrizoate; Filtration; Nanotechnology; Oxidants; Oxidation-Reduction; Ozone; Recycling; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Purification | 2016 |
Different effects of selective β1-adrenoceptor antagonists, nebivolol or atenolol in acetaminophen-induced hepatotoxicity of rats.
Topics: Acetaminophen; Adrenergic beta-1 Receptor Antagonists; Analgesics, Non-Narcotic; Animals; Antioxidants; Atenolol; Blood Pressure; Chemical and Drug Induced Liver Injury; Drug Overdose; Glutathione; Heart Rate; Male; Malondialdehyde; Nebivolol; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Wistar | 2017 |
Transcriptome analysis of the brain of the sea bream (Sparus aurata) after exposure to human pharmaceuticals at realistic environmental concentrations.
Topics: Acetaminophen; Animals; Atenolol; Biomarkers; Brain; Carbamazepine; Fish Proteins; Gene Expression Profiling; Pharmaceutical Preparations; Sea Bream; Transcriptome; Water Pollutants, Chemical | 2017 |
Ozonation as a pretreatment process for nanofiltration brines: Monitoring of transformation products and toxicity evaluation.
Topics: Acetaminophen; Atenolol; Carbamazepine; Chromatography, Liquid; Filtration; Membranes, Artificial; Nanotechnology; Osmosis; Ozone; Salts; Tandem Mass Spectrometry; Toxicity Tests, Acute; Wastewater; Water Pollutants, Chemical; Water Purification | 2017 |
Fixed dose combinations for cardiovascular treatment via coaxial electrospraying: Coated amorphous solid dispersion particles.
Topics: Acetaminophen; Aspirin; Atenolol; Drug Combinations; Drug Compounding; Drug Liberation; Fenofibrate; Hydrogen-Ion Concentration; Polyethylene Glycols; Polymethacrylic Acids; Polyvinyls; Powders | 2020 |
In-Syringe Electrokinetic Protein Removal from Biological Samples prior to Electrospray Ionization Mass Spectrometry.
Topics: Acetaminophen; Atenolol; Blood Proteins; Chlorpheniramine; Clomipramine; Humans; Kinetics; Naproxen; Pindolol; Spectrometry, Mass, Electrospray Ionization; Syringes | 2020 |
Novel organic assisted Ag-ZnO photocatalyst for atenolol and acetaminophen photocatalytic degradation under visible radiation: performance and reaction mechanism.
Topics: Acetaminophen; Atenolol; Catalysis; Light; Silver; Spectroscopy, Fourier Transform Infrared; Zinc Oxide | 2021 |
First report on the occurrence of pharmaceuticals and cocaine in the coastal waters of Santa Catarina, Brazil, and its related ecological risk assessment.
Topics: Acetaminophen; Atenolol; Brazil; Caffeine; Carbamazepine; Chromatography, Liquid; Cocaine; Cosmetics; Diclofenac; Ecosystem; Environmental Monitoring; Humans; Losartan; Orphenadrine; Pharmaceutical Preparations; Risk Assessment; Sewage; Solid Waste; Tandem Mass Spectrometry; Water; Water Pollutants, Chemical | 2022 |
Occurrence, ecological risk assessment and prioritization of pharmaceuticals and abuse drugs in estuarine waters along the São Paulo coast, Brazil.
Topics: Acetaminophen; Atenolol; Brazil; Caffeine; Carbamazepine; Chromatography, Liquid; Cocaine; Diclofenac; Ecosystem; Environmental Monitoring; Furosemide; Illicit Drugs; Losartan; Orphenadrine; Pharmaceutical Preparations; Risk Assessment; Rivers; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2022 |
Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors.
Topics: Acetaminophen; Atenolol; Biodegradation, Environmental; Bioreactors; Caffeine; Environmental Pollutants; Ibuprofen; Microbiota; Pharmaceutical Preparations; RNA, Ribosomal, 16S; Water Pollutants, Chemical | 2023 |